Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

October 2023

Terapia com inibidores de JAK ou bDMARDs e o risco de eventos cardiovasculares na população holandesa com artrite reumatoide

Rheumatology (Oxford) 2023 doi 10.1093/rheumatology/kead531 Epub ahead of print

Popa CD,

This retrospective inception cohort study investigated RA patients starting a new bDMARD or JAKi prescription between 01 August 2018 and 31 January 2022 from IQVIA’s Dutch Real-World Data Longitudinal Prescription database.

Keywords:

JAK,
Cardiovascular